EUVIMEDEUVIMED entdecken
Crossref

CD44‐Assisted Transcytosable Chimeras for Extracellular Protein Depletion in Deep Tumors

Xinlu Xu, Jingxing Si, Jingwen Xie, Jing Tan, Yumiao Guo, Gaoxia Ma, Shasha Yao, Yi Wang, Yuping Chen, Youqing Shen, Shiqun Shao iD

Angewandte Chemie International Edition · 2026

DOI: 10.1002/anie.202521770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Xinlu Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University,…. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Transcytosis, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular targeted protein degradation (eTPD) typically uses antibody‐derived bifunctional chimeras to direct extracellular targets toward lysosomal degradation. However, the requirements for antibody modification complicate degrader design, and their large size hinders tissue penetration. While small‐molecule degraders provide enhanced tissue permeability, they suffer from poor pharmacokinetics and a limited target scope. Here we develop CD44‐Assisted Transcytosable CHimeras (CATCHs), a plug‐and‐play platform that leverages CD44‐mediated transcytosis for extracellular protein depletion in deep tumors. CATCHs are built on a hyaluronan‐containing nanoparticle chassis, functionalized with IgG‐affinitive tags to recruit unmodified antibodies. This design enables rapid generation of CATCHs against diverse targets. We show that CATCHs can drive near‐complete depletion of cell‐surface proteins, including PD‐L1 and HER2, within 3 h at single‐digit nanomolar antibody concentrations. Mechanistic studies reveal that CATCHs remove target proteins in a CD44‐dependent manner through not only lysosomal proteolysis but also transcytosis of protein targets into extracellular spaces. The transcytosis‐inducing activity also allows CATCHs to penetrate deep tumor tissues via consecutive transcytosis and effectuate depletion in otherwise inaccessible regions. We show that PD‐L1‐targeting CATCHs could induce potent antitumor immunity by depleting PD‐L1 throughout tumor tissues. This platform promises a versatile eTPD tool with implications for both biomedical research and therapeutic drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsTranscytosisNeoplasmsHumansAnimalsHyaluronic AcidNanoparticlesCell Line, TumorProteolysis

Stichwörter der Autor:innen

CD44extracellular targeted protein degradationhyaluronic acidlysosomal degradationtranscytosis

Substanzen

Hyaluronan ReceptorsCD44 protein, humanHyaluronic Acid

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang, China.
  • General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zh…
  • Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

ORCID-Profile: Shiqun Shao

Förderung

  • Zhejiang Provincial Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • National Science and Technology Major Project of China
  • "Pioneer" and "Leading Goose" R&D Program of Zhejiang
  • Zhejiang Medicine and Health Science and Technology Project
  • National Key Research and Development Program of China

Zitieren

APA

Xu, X., Si, J., Xie, J., Tan, J., Guo, Y., Ma, G., Yao, S., Wang, Y., Chen, Y., Shen, Y., & Shao, S. (2026). CD44‐Assisted Transcytosable Chimeras for Extracellular Protein Depletion in Deep Tumors. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202521770

Vancouver

Xu X, Si J, Xie J, Tan J, Guo Y, Ma G, et al. CD44‐Assisted Transcytosable Chimeras for Extracellular Protein Depletion in Deep Tumors. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202521770

BibTeX
@article{Xu2026,
  author = {Xu, Xinlu and Si, Jingxing and Xie, Jingwen and Tan, Jing and Guo, Yumiao and Ma, Gaoxia and Yao, Shasha and Wang, Yi and Chen, Yuping and Shen, Youqing and Shao, Shiqun},
  title = {CD44‐Assisted Transcytosable Chimeras for Extracellular Protein Depletion in Deep Tumors},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.202521770}
}
Kostenlos starten →